세계의 백신 시장예측 2021년-2026년

■ 영문 제목 : Global Vaccine Market Growth (Status and Outlook) 2021-2026

LP Information가 발행한 조사보고서이며, 코드는 LPI-2201K02208 입니다.■ 상품코드 : LPI-2201K02208
■ 조사/발행회사 : LP Information
■ 발행일 : 2021년 12월 (※2025년 최신판이 있습니다. 문의 주세요.)
■ 페이지수 : 118
■ 작성언어 : 영어
■ 보고서 형태 : PDF
■ 납품 방식 : E메일
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1명 열람용)USD3,660 ⇒환산￦5,124,000견적의뢰/주문/질문
Multi User (5명 열람용)USD5,490 ⇒환산￦7,686,000견적의뢰/주문/질문
Corporate User (동일기업내 공유가능)USD7,320 ⇒환산￦10,248,000견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
본 조사보고서는 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아, 러시아, 중동/아프리카, 이집트, 남아프리카, 터키, 중동GCC국 등), 시장동향, 판매/유통업자/고객 리스트, 시장예측 (2021년-2026년), 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익) 등의 정보를 포함하고 있습니다. 또한, 주요지역의 종류별 시장규모 (수두 백신, 인플루엔자 백신, 폴리오 백신, A형 간염 백신, 광견병 백신, BCG백신, B형 간염, 페르츠시스, 디프테리아, 파상풍, 폐렴 구균, 기타)와 용도별 시장규모 (성인용, 어린이용) 데이터도 수록되어 있습니다.
- 조사 범위
- 경영자용 요약
- 기업별 백신 시장 점유율
- 지역별 백신 시장규모
- 주요지역의 종류별 시장규모 (수두 백신, 인플루엔자 백신, 폴리오 백신, A형 간염 백신, 광견병 백신, BCG백신, B형 간염, 페르츠시스, 디프테리아, 파상풍, 폐렴 구균, 기타)
- 주요지역의 용도별 시장규모 (성인용, 어린이용)
- 미주의 백신 시장규모 (미국, 캐나다, 멕시코, 브라질 등)
- 아시아의 백신 시장규모 (중국, 일본, 한국, 동남아시아, 인도 등)
- 유럽의 백신 시장규모 (독일, 프랑스, 영국, 이탈리아, 러시아 등)
- 중동/아프리카의 백신 시장규모 (이집트, 남아프리카, 터키, 중동GCC지역 등)
- 시장의 성장요인, 과제, 동향
- 마케팅, 유통업자, 고객리스트
- 세계의 백신 시장예측 (2021년-2026년)
- 주요 기업동향 (기업정보, 제품, 판매량, 매출, 가격, 매출총이익)
AstraZeneca, BioNTech, Boehringer-Ingelheim, CCBIO, CSL, CureVac, Elanco, GSK, Hulan Bio, Indian Immunologicals, Merck, Minhai Biotechnology, Mitsubishi Tanabe Pharma, Moderna Therapeutics, Mylan, Plumbline Life Sciences, Sanofi, Translate Bio, Walvax Biotechnology, Wuhan Institute of Biological Products, Zoties
- 조사의 결과/결론
■ 보고서 개요

According to this latest study, the 2021 growth of Vaccine will have significant change from previous year. By the most conservative estimates of global Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vaccine market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Varicella Vaccine
Influenza Vaccine
Polio Vaccine
Hepatitis A Vaccine
Rabies Vaccine
BCG Vaccine
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Others

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
For Adult
For Child

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
BioNTech
Boehringer-Ingelheim
CCBIO
CSL
CureVac
Elanco
GSK
Hulan Bio
Indian Immunologicals
Merck
Minhai Biotechnology
Mitsubishi Tanabe Pharma
Moderna Therapeutics
Mylan
Plumbline Life Sciences
Sanofi
Translate Bio
Walvax Biotechnology
Wuhan Institute of Biological Products
Zoties

■ 보고서 목차

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vaccine Market Size 2016-2026
2.1.2 Vaccine Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Vaccine Segment by Type
2.2.1 Varicella Vaccine
2.2.2 Varicella Vaccine
2.2.3 Polio Vaccine
2.2.4 Hepatitis A Vaccine
2.2.5 Rabies Vaccine
2.2.6 BCG Vaccine
2.2.7 Hepatitis B
2.2.8 Pertussis, Diphtheria, Tetanus
2.2.9 Pneumococcal
2.2.10 Others
2.3 Vaccine Market Size by Type
2.3.1 Global Vaccine Market Size CAGR by Type
2.3.2 Global Vaccine Market Size Market Share by Type (2016-2021)
2.4 Vaccine Segment by Application
2.4.1 For Adult
2.4.2 For Child
2.5 Vaccine Market Size by Application
2.5.1 Global Vaccine Market Size CAGR by Application
2.5.2 Global Vaccine Market Size Market Share by Application (2016-2021)

3 Vaccine Market Size by Players
3.1 Vaccine Market Size Market Share by Players
3.1.1 Global Vaccine Revenue by Players (2019-2021E)
3.1.2 Global Vaccine Revenue Market Share by Players (2019-2021E)
3.2 Global Vaccine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Vaccine by Regions
4.1 Vaccine Market Size by Regions (2016-2021)
4.2 Americas Vaccine Market Size Growth (2016-2021)
4.3 APAC Vaccine Market Size Growth (2016-2021)
4.4 Europe Vaccine Market Size Growth (2016-2021)
4.5 Middle East & Africa Vaccine Market Size Growth (2016-2021)

5 Americas
5.1 Americas Vaccine Market Size by Country (2016-2021)
5.2 Americas Vaccine Market Size by Type (2016-2021)
5.3 Americas Vaccine Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Vaccine Market Size by Region (2016-2021)
6.2 APAC Vaccine Market Size by Type (2016-2021)
6.3 APAC Vaccine Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Vaccine by Country (2016-2021)
7.2 Europe Vaccine Market Size by Type (2016-2021)
7.3 Europe Vaccine Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Vaccine by Region (2016-2021)
8.2 Middle East & Africa Vaccine Market Size by Type (2016-2021)
8.3 Middle East & Africa Vaccine Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Vaccine Market Forecast
10.1 Global Vaccine Forecast by Regions (2021-2026)
10.1.1 Global Vaccine Forecast by Regions (2021-2026)
10.1.2 Americas Vaccine Forecast
10.1.3 APAC Vaccine Forecast
10.1.4 Europe Vaccine Forecast
10.1.5 Middle East & Africa Vaccine Forecast
10.2 Americas Vaccine Forecast by Countries (2021-2026)
10.2.1 United States Vaccine Market Forecast
10.2.2 Canada Vaccine Market Forecast
10.2.3 Mexico Vaccine Market Forecast
10.2.4 Brazil Vaccine Market Forecast
10.3 APAC Vaccine Forecast by Region (2021-2026)
10.3.1 China Vaccine Market Forecast
10.3.2 Japan Vaccine Market Forecast
10.3.3 Korea Vaccine Market Forecast
10.3.4 Southeast Asia Vaccine Market Forecast
10.3.5 India Vaccine Market Forecast
10.3.6 Australia Vaccine Market Forecast
10.4 Europe Vaccine Forecast by Country (2021-2026)
10.4.1 Germany Vaccine Market Forecast
10.4.2 France Vaccine Market Forecast
10.4.3 UK Vaccine Market Forecast
10.4.4 Italy Vaccine Market Forecast
10.4.5 Russia Vaccine Market Forecast
10.5 Middle East & Africa Vaccine Forecast by Region (2021-2026)
10.5.1 Egypt Vaccine Market Forecast
10.5.2 South Africa Vaccine Market Forecast
10.5.3 Israel Vaccine Market Forecast
10.5.4 Turkey Vaccine Market Forecast
10.5.5 GCC Countries Vaccine Market Forecast
10.6 Global Vaccine Forecast by Type (2021-2026)
10.7 Global Vaccine Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 AstraZeneca
11.1.1 AstraZeneca Company Information
11.1.2 AstraZeneca Vaccine Product Offered
11.1.3 AstraZeneca Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 AstraZeneca Main Business Overview
11.1.5 AstraZeneca Latest Developments
11.2 BioNTech
11.2.1 BioNTech Company Information
11.2.2 BioNTech Vaccine Product Offered
11.2.3 BioNTech Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 BioNTech Main Business Overview
11.2.5 BioNTech Latest Developments
11.3 Boehringer-Ingelheim
11.3.1 Boehringer-Ingelheim Company Information
11.3.2 Boehringer-Ingelheim Vaccine Product Offered
11.3.3 Boehringer-Ingelheim Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Boehringer-Ingelheim Main Business Overview
11.3.5 Boehringer-Ingelheim Latest Developments
11.4 CCBIO
11.4.1 CCBIO Company Information
11.4.2 CCBIO Vaccine Product Offered
11.4.3 CCBIO Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 CCBIO Main Business Overview
11.4.5 CCBIO Latest Developments
11.5 CSL
11.5.1 CSL Company Information
11.5.2 CSL Vaccine Product Offered
11.5.3 CSL Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 CSL Main Business Overview
11.5.5 CSL Latest Developments
11.6 CureVac
11.6.1 CureVac Company Information
11.6.2 CureVac Vaccine Product Offered
11.6.3 CureVac Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 CureVac Main Business Overview
11.6.5 CureVac Latest Developments
11.7 Elanco
11.7.1 Elanco Company Information
11.7.2 Elanco Vaccine Product Offered
11.7.3 Elanco Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Elanco Main Business Overview
11.7.5 Elanco Latest Developments
11.8 GSK
11.8.1 GSK Company Information
11.8.2 GSK Vaccine Product Offered
11.8.3 GSK Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 GSK Main Business Overview
11.8.5 GSK Latest Developments
11.9 Hulan Bio
11.9.1 Hulan Bio Company Information
11.9.2 Hulan Bio Vaccine Product Offered
11.9.3 Hulan Bio Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Hulan Bio Main Business Overview
11.9.5 Hulan Bio Latest Developments
11.10 Indian Immunologicals
11.10.1 Indian Immunologicals Company Information
11.10.2 Indian Immunologicals Vaccine Product Offered
11.10.3 Indian Immunologicals Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Indian Immunologicals Main Business Overview
11.10.5 Indian Immunologicals Latest Developments
11. Merck
11.11.1 Merck Company Information
11.11.2 Merck Vaccine Product Offered
11.11.3 Merck Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 Merck Main Business Overview
11.11.5 Merck Latest Developments
11.12 Minhai Biotechnology
11.12.1 Minhai Biotechnology Company Information
11.12.2 Minhai Biotechnology Vaccine Product Offered
11.12.3 Minhai Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Minhai Biotechnology Main Business Overview
11.12.5 Minhai Biotechnology Latest Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Company Information
11.13.2 Mitsubishi Tanabe Pharma Vaccine Product Offered
11.13.3 Mitsubishi Tanabe Pharma Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Mitsubishi Tanabe Pharma Main Business Overview
11.13.5 Mitsubishi Tanabe Pharma Latest Developments
11.14 Moderna Therapeutics
11.14.1 Moderna Therapeutics Company Information
11.14.2 Moderna Therapeutics Vaccine Product Offered
11.14.3 Moderna Therapeutics Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Moderna Therapeutics Main Business Overview
11.14.5 Moderna Therapeutics Latest Developments
11.15 Mylan
11.15.1 Mylan Company Information
11.15.2 Mylan Vaccine Product Offered
11.15.3 Mylan Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Mylan Main Business Overview
11.15.5 Mylan Latest Developments
11.16 Plumbline Life Sciences
11.16.1 Plumbline Life Sciences Company Information
11.16.2 Plumbline Life Sciences Vaccine Product Offered
11.16.3 Plumbline Life Sciences Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Plumbline Life Sciences Main Business Overview
11.16.5 Plumbline Life Sciences Latest Developments
11.17 Sanofi
11.17.1 Sanofi Company Information
11.17.2 Sanofi Vaccine Product Offered
11.17.3 Sanofi Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Sanofi Main Business Overview
11.17.5 Sanofi Latest Developments
11.18 Translate Bio
11.18.1 Translate Bio Company Information
11.18.2 Translate Bio Vaccine Product Offered
11.18.3 Translate Bio Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Translate Bio Main Business Overview
11.18.5 Translate Bio Latest Developments
11.19 Walvax Biotechnology
11.19.1 Walvax Biotechnology Company Information
11.19.2 Walvax Biotechnology Vaccine Product Offered
11.19.3 Walvax Biotechnology Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Walvax Biotechnology Main Business Overview
11.19.5 Walvax Biotechnology Latest Developments
11.20 Wuhan Institute of Biological Products
11.20.1 Wuhan Institute of Biological Products Company Information
11.20.2 Wuhan Institute of Biological Products Vaccine Product Offered
11.20.3 Wuhan Institute of Biological Products Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Wuhan Institute of Biological Products Main Business Overview
11.20.5 Wuhan Institute of Biological Products Latest Developments
11.21 Zoties
11.21.1 Zoties Company Information
11.21.2 Zoties Vaccine Product Offered
11.21.3 Zoties Vaccine Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 Zoties Main Business Overview
11.21.5 Zoties Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Vaccine Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Varicella Vaccine
Table 3. Major Players of Influenza Vaccine
Table 4. Major Players of Polio Vaccine
Table 5. Major Players of Hepatitis A Vaccine
Table 6. Major Players of Rabies Vaccine
Table 7. Major Players of BCG Vaccine
Table 8. Major Players of Hepatitis B
Table 9. Major Players of Pertussis, Diphtheria, Tetanus
Table 10. Major Players of Pneumococcal
Table 11. Major Players of Others
Table 12. Vaccine Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 13. Global Vaccine Market Size by Type (2016-2021) & ($ Millions)
Table 14. Global Vaccine Market Size Market Share by Type (2016-2021)
Table 15. Vaccine Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 16. Global Vaccine Market Size by Application (2016-2021) & ($ Millions)
Table 17. Global Vaccine Market Size Market Share by Application (2016-2021)
Table 18. Global Vaccine Revenue by Players (2019-2021E) & ($ Millions)
Table 19. Global Vaccine Revenue Market Share by Players (2019-2021E)
Table 20. Vaccine Key Players Head office and Products Offered
Table 21. Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 22. New Products and Potential Entrants
Table 23. Mergers & Acquisitions, Expansion
Table 24. Global Vaccine Market Size by Regions 2016-2021 & ($ Millions)
Table 25. Global Vaccine Market Size Market Share by Regions 2016-2021
Table 26. Americas Vaccine Market Size by Country (2016-2021) & ($ Millions)
Table 27. Americas Vaccine Market Size Market Share by Country (2016-2021)
Table 28. Americas Vaccine Market Size by Type (2016-2021) & ($ Millions)
Table 29. Americas Vaccine Market Size Market Share by Type (2016-2021)
Table 30. Americas Vaccine Market Size by Application (2016-2021) & ($ Millions)
Table 31. Americas Vaccine Market Size Market Share by Application (2016-2021)
Table 32. APAC Vaccine Market Size by Region (2016-2021) & ($ Millions)
Table 33. APAC Vaccine Market Size Market Share by Region (2016-2021)
Table 34. APAC Vaccine Market Size by Type (2016-2021) & ($ Millions)
Table 35. APAC Vaccine Market Size Market Share by Type (2016-2021)
Table 36. APAC Vaccine Market Size by Application (2016-2021) & ($ Millions)
Table 37. APAC Vaccine Market Size Market Share by Application (2016-2021)
Table 38. Europe Vaccine Market Size by Country (2016-2021) & ($ Millions)
Table 39. Europe Vaccine Market Size Market Share by Country (2016-2021)
Table 40. Europe Vaccine Market Size by Type (2016-2021) & ($ Millions)
Table 41. Europe Vaccine Market Size Market Share by Type (2016-2021)
Table 42. Europe Vaccine Market Size by Application (2016-2021) & ($ Millions)
Table 43. Europe Vaccine Market Size Market Share by Application (2016-2021)
Table 44. Middle East & Africa Vaccine Market Size by Region (2016-2021) & ($ Millions)
Table 45. Middle East & Africa Vaccine Market Size Market Share by Region (2016-2021)
Table 46. Middle East & Africa Vaccine Market Size by Type (2016-2021) & ($ Millions)
Table 47. Middle East & Africa Vaccine Market Size Market Share by Type (2016-2021)
Table 48. Middle East & Africa Vaccine Market Size by Application (2016-2021) & ($ Millions)
Table 49. Middle East & Africa Vaccine Market Size Market Share by Application (2016-2021)
Table 50. Key and Potential Regions of Vaccine
Table 51. Key Application and Potential Industries of Vaccine
Table 52. Key Challenges of Vaccine
Table 53. Key Trends of Vaccine
Table 54. Global Vaccine Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 55. Global Vaccine Market Size Market Share Forecast by Regions (2021-2026)
Table 56. Global Vaccine Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 57. Global Vaccine Market Size Market Share Forecast by Type (2021-2026)
Table 58. Global Vaccine Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 59. Global Vaccine Market Size Market Share Forecast by Application (2021-2026)
Table 60. AstraZeneca Details, Company Type, Vaccine Area Served and Its Competitors
Table 61. AstraZeneca Vaccine Product Offered
Table 62. AstraZeneca Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 63. AstraZeneca Main Business
Table 64. AstraZeneca Latest Developments
Table 65. BioNTech Details, Company Type, Vaccine Area Served and Its Competitors
Table 66. BioNTech Vaccine Product Offered
Table 67. BioNTech Main Business
Table 68. BioNTech Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 69. BioNTech Latest Developments
Table 70. Boehringer-Ingelheim Details, Company Type, Vaccine Area Served and Its Competitors
Table 71. Boehringer-Ingelheim Vaccine Product Offered
Table 72. Boehringer-Ingelheim Main Business
Table 73. Boehringer-Ingelheim Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 74. Boehringer-Ingelheim Latest Developments
Table 75. CCBIO Details, Company Type, Vaccine Area Served and Its Competitors
Table 76. CCBIO Vaccine Product Offered
Table 77. CCBIO Main Business
Table 78. CCBIO Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 79. CCBIO Latest Developments
Table 80. CSL Details, Company Type, Vaccine Area Served and Its Competitors
Table 81. CSL Vaccine Product Offered
Table 82. CSL Main Business
Table 83. CSL Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 84. CSL Latest Developments
Table 85. CureVac Details, Company Type, Vaccine Area Served and Its Competitors
Table 86. CureVac Vaccine Product Offered
Table 87. CureVac Main Business
Table 88. CureVac Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 89. CureVac Latest Developments
Table 90. Elanco Details, Company Type, Vaccine Area Served and Its Competitors
Table 91. Elanco Vaccine Product Offered
Table 92. Elanco Main Business
Table 93. Elanco Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 94. Elanco Latest Developments
Table 95. GSK Details, Company Type, Vaccine Area Served and Its Competitors
Table 96. GSK Vaccine Product Offered
Table 97. GSK Main Business
Table 98. GSK Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 99. GSK Latest Developments
Table 100. Hulan Bio Details, Company Type, Vaccine Area Served and Its Competitors
Table 101. Hulan Bio Vaccine Product Offered
Table 102. Hulan Bio Main Business
Table 103. Hulan Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 104. Hulan Bio Latest Developments
Table 105. Indian Immunologicals Details, Company Type, Vaccine Area Served and Its Competitors
Table 106. Indian Immunologicals Vaccine Product Offered
Table 107. Indian Immunologicals Main Business
Table 108. Indian Immunologicals Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 109. Indian Immunologicals Latest Developments
Table 110. Merck Details, Company Type, Vaccine Area Served and Its Competitors
Table 111. Merck Vaccine Product Offered
Table 112. Merck Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 113. Merck Main Business
Table 114. Merck Latest Developments
Table 115. Minhai Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors
Table 116. Minhai Biotechnology Vaccine Product Offered
Table 117. Minhai Biotechnology Main Business
Table 118. Minhai Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 119. Minhai Biotechnology Latest Developments
Table 120. Mitsubishi Tanabe Pharma Details, Company Type, Vaccine Area Served and Its Competitors
Table 121. Mitsubishi Tanabe Pharma Vaccine Product Offered
Table 122. Mitsubishi Tanabe Pharma Main Business
Table 123. Mitsubishi Tanabe Pharma Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 124. Mitsubishi Tanabe Pharma Latest Developments
Table 125. Moderna Therapeutics Details, Company Type, Vaccine Area Served and Its Competitors
Table 126. Moderna Therapeutics Vaccine Product Offered
Table 127. Moderna Therapeutics Main Business
Table 128. Moderna Therapeutics Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 129. Moderna Therapeutics Latest Developments
Table 130. Mylan Details, Company Type, Vaccine Area Served and Its Competitors
Table 131. Mylan Vaccine Product Offered
Table 132. Mylan Main Business
Table 133. Mylan Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 134. Mylan Latest Developments
Table 135. Plumbline Life Sciences Details, Company Type, Vaccine Area Served and Its Competitors
Table 136. Plumbline Life Sciences Vaccine Product Offered
Table 137. Plumbline Life Sciences Main Business
Table 138. Plumbline Life Sciences Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 139. Plumbline Life Sciences Latest Developments
Table 140. Sanofi Details, Company Type, Vaccine Area Served and Its Competitors
Table 141. Sanofi Vaccine Product Offered
Table 142. Sanofi Main Business
Table 143. Sanofi Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 144. Sanofi Latest Developments
Table 145. Translate Bio Details, Company Type, Vaccine Area Served and Its Competitors
Table 146. Translate Bio Vaccine Product Offered
Table 147. Translate Bio Main Business
Table 148. Translate Bio Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 149. Translate Bio Latest Developments
Table 150. Walvax Biotechnology Details, Company Type, Vaccine Area Served and Its Competitors
Table 151. Walvax Biotechnology Vaccine Product Offered
Table 152. Walvax Biotechnology Main Business
Table 153. Walvax Biotechnology Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 154. Walvax Biotechnology Latest Developments
Table 155. Wuhan Institute of Biological Products Details, Company Type, Vaccine Area Served and Its Competitors
Table 156. Wuhan Institute of Biological Products Vaccine Product Offered
Table 157. Wuhan Institute of Biological Products Main Business
Table 158. Wuhan Institute of Biological Products Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 159. Wuhan Institute of Biological Products Latest Developments
Table 160. Zoties Details, Company Type, Vaccine Area Served and Its Competitors
Table 161. Zoties Vaccine Product Offered
Table 162. Zoties Vaccine Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 163. Zoties Main Business
Table 164. Zoties Latest Developments
List of Figures
Figure 1. Vaccine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Vaccine Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Vaccine Market Size Market Share by Type in 2020
Figure 7. Vaccine in For Adult
Figure 8. Global Vaccine Market: For Adult (2016-2021) & ($ Millions)
Figure 9. Vaccine in For Child
Figure 10. Global Vaccine Market: For Child (2016-2021) & ($ Millions)
Figure 11. Global Vaccine Market Size Market Share by Application in 2020
Figure 12. Global Vaccine Revenue Market Share by Player in 2020
Figure 13. Global Vaccine Market Size Market Share by Regions (2016-2021)
Figure 14. Americas Vaccine Market Size 2016-2021 ($ Millions)
Figure 15. APAC Vaccine Market Size 2016-2021 ($ Millions)
Figure 16. Europe Vaccine Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa Vaccine Market Size 2016-2021 ($ Millions)
Figure 18. Americas Vaccine Market Size Market Share by Country in 2020
Figure 19. Americas Vaccine Market Size Market Share by Type in 2020
Figure 20. Americas Vaccine Market Size Market Share by Application in 2020
Figure 21. United States Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC Vaccine Market Size Market Share by Regions in 2020
Figure 25. APAC Vaccine Market Size Market Share by Type in 2020
Figure 26. APAC Vaccine Market Size Market Share by Application in 2020
Figure 27. China Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 31. India Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe Vaccine Market Size Market Share by Country in 2020
Figure 34. Europe Vaccine Market Size Market Share by Type in 2020
Figure 35. Europe Vaccine Market Size Market Share by Application in 2020
Figure 36. Germany Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 37. France Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa Vaccine Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa Vaccine Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa Vaccine Market Size Market Share by Application in 2020
Figure 44. Egypt Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country Vaccine Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas Vaccine Market Size 2021-2026 ($ Millions)
Figure 50. APAC Vaccine Market Size 2021-2026 ($ Millions)
Figure 51. Europe Vaccine Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa Vaccine Market Size 2021-2026 ($ Millions)
Figure 53. United States Vaccine Market Size 2021-2026 ($ Millions)
Figure 54. Canada Vaccine Market Size 2021-2026 ($ Millions)
Figure 55. Mexico Vaccine Market Size 2021-2026 ($ Millions)
Figure 56. Brazil Vaccine Market Size 2021-2026 ($ Millions)
Figure 57. China Vaccine Market Size 2021-2026 ($ Millions)
Figure 58. Japan Vaccine Market Size 2021-2026 ($ Millions)
Figure 59. Korea Vaccine Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia Vaccine Market Size 2021-2026 ($ Millions)
Figure 61. India Vaccine Market Size 2021-2026 ($ Millions)
Figure 62. Australia Vaccine Market Size 2021-2026 ($ Millions)
Figure 63. Germany Vaccine Market Size 2021-2026 ($ Millions)
Figure 64. France Vaccine Market Size 2021-2026 ($ Millions)
Figure 65. UK Vaccine Market Size 2021-2026 ($ Millions)
Figure 66. Italy Vaccine Market Size 2021-2026 ($ Millions)
Figure 67. Russia Vaccine Market Size 2021-2026 ($ Millions)
Figure 68. Spain Vaccine Market Size 2021-2026 ($ Millions)
Figure 69. Egypt Vaccine Market Size 2021-2026 ($ Millions)
Figure 70. South Africa Vaccine Market Size 2021-2026 ($ Millions)
Figure 71. Israel Vaccine Market Size 2021-2026 ($ Millions)
Figure 72. Turkey Vaccine Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country Vaccine Market Size 2021-2026 ($ Millions)
※본 조사보고서 [세계의 백신 시장예측 2021년-2026년] (코드 : LPI-2201K02208) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 백신 시장예측 2021년-2026년] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 조사자료도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

  • 세계의 백신 투여 시장예측 2021년-2026년
    LPI-2201K02327 / LP Information / 2021년 12월 / 본 조사보고서는 백신 투여의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Vaccine Administration will have significant change from previous year. By the most conservative estimates of global Vaccine Administration market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...
  • 세계의 비강 스프레이 인플루엔자 백신 시장예측 2021년-2026년
    LPI-2201K02102 / LP Information / 2021년 12월 / 본 조사보고서는 비강 스프레이 인플루엔자 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스,...According to this latest study, the 2021 growth of Nasal Spray Influenza Vaccine will have significant change from previous year. By the most conservative estimates of global Nasal Spray Influenza Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...
  • 세계의 폐렴구균 백신 시장예측 2021년-2026년
    LPI-2201K02154 / LP Information / 2021년 12월 / 본 조사보고서는 폐렴구균 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Pneumococcal Bacteria Vaccine will have significant change from previous year. By the most conservative estimates of global Pneumococcal Bacteria Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in...
  • 세계의 종양 세포 백신 시장예측 2021년-2026년
    LPI-2201K02666 / LP Information / 2021년 12월 / 본 조사보고서는 종양 세포 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of Tumour-cell Vaccine will have significant change from previous year. By the most conservative estimates of global Tumour-cell Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over...
  • 세계의 SARS-Cov-2 백신 (베로셀) 시장예측 2021년-2026년
    LPI-2201K02170 / LP Information / 2021년 12월 / 본 조사보고서는 SARS-Cov-2 백신 (베로셀)의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국,...According to this latest study, the 2021 growth of SARS-Cov-2 Vaccine (Vero Cell) will have significant change from previous year. By the most conservative estimates of global SARS-Cov-2 Vaccine (Vero Cell) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx...
  • 세계의 수두 백신 시장예측 2021년-2026년
    LPI-2201K02212 / LP Information / 2021년 12월 / 본 조사보고서는 수두 백신의 세계시장에 관해서 조사, 분석한 자료로서, 기업별 시장 점유율, 지역별 시장규모 (미주, 미국, 캐나다, 멕시코, 브라질, 아시아, 중국, 일본, 한국, 동남아시아, 인도, 유럽, 독일, 프랑스, 영국, 이탈리아,...According to this latest study, the 2021 growth of Varicella Vaccine will have significant change from previous year. By the most conservative estimates of global Varicella Vaccine market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ 3787.8 million in 2020. Over...